Benchling for Antibody Therapeutics R&D
Antibodies are an important class of therapeutic agents which have evolved significantly over the past 30 years. Antibody R&D is now more streamlined than ever, but several factors continue to contribute to its complexity.
This application note provides:
An outline of the complexities present in antibody research and development
How Benchling’s capabilities can solve these complexities